Silq Technologies Corporation

Silq Technologies is a leader in advanced biomaterials and surface treatment technology. The company has developed a patented zwitterionic surface treatment platform that resists the adhesion of organic material, proteins, and bacteria without antibiotics or antimicrobials. This FDA-cleared technology is designed to reduce biofilm formation, encrustation, and infection risk in medical devices and implants while improving patient comfort through enhanced lubricity. Silq's scalable manufacturing platform enables contract surface treatment services for medical device manufacturers and industrial applications, including urological devices, catheters, microfluidics, and water treatment systems. The company's flagship product, ClearTract SPT® Foley Catheters, demonstrates significant clinical benefits in reducing complications and healthcare costs associated with catheter-related infections and blockages.